The European Organisation for Research and Treatment of Cancer (EORTC) celebrates its 60th Anniversary
The European Organisation for Research and Treatment of Cancer (EORTC) celebrates its 60th Anniversary this year. Join EORTC for this important event on Friday September 30th, 2022 in Brussels! Beyond revisiting this organisation’s remarkable achievements, the event...
The FDA’s Pazdur on accelerated approval, single-arm studies, and his own future
Adam Feuerstein (Senior Writer, STAT) published the article, "The FDA’s Pazdur on accelerated approval, single-arm studies, and his own future" on 4 June 2022. To read the full article,CLICK HERE
CDDF: Announcement of Newly Elected Leadership
The Cancer Drug Development Forum Announces Newly Elected Leadership The Cancer Drug Development Forum (CDDF) is delighted to announce newly elected leadership, appointed at its General Assembly on 1 June 2022. Please join us in welcoming former...
CDDF Annual Report 2021
The CDDF has published its 2021 annual report which highlights the steps the association has taken to further its mission in the year in order to stimulate advancement in cancer drug development and access. To read the report, click the following link: CDDF Annual...
EOTRC Stats Course: Clinical Trial Statistics for Non-Statisticians (14-17 June 2022, Brussels)
EORTC Statistics Course (14-17 June 2022, Brussels) Develop the statistical knowledge required to better understand today’s cancer clinical trials! The EORTC provides an introduction to the statistical methods used for the design, conduct and analysis of cancer...
NEW CDDF BROCHURE
Read the latest version of the CDDF brochure HERE!
European Pharmaceutical Review (Dec, 2021): CDDF Article
The CDDF's article on "United efforts to accelerate drug development" has been published in the European Pharmaceutical Review (Dec, 2021). In the article, Prof. John Smyth (Chairman), Prof. Axel Glasmacher (Treasurer) and Prof. Jaap Verweij (Managing Director)...
Happy Christmas!
The CDDF team wishes you a happy holiday season! Thank you for your continued support and collaboration in 2021.